CN116790647B - 一种低背景、高信号强度的2-吡咯烷酮生物传感器及应用 - Google Patents
一种低背景、高信号强度的2-吡咯烷酮生物传感器及应用 Download PDFInfo
- Publication number
- CN116790647B CN116790647B CN202310068615.7A CN202310068615A CN116790647B CN 116790647 B CN116790647 B CN 116790647B CN 202310068615 A CN202310068615 A CN 202310068615A CN 116790647 B CN116790647 B CN 116790647B
- Authority
- CN
- China
- Prior art keywords
- promoter
- pyrrolidone
- biosensor
- chnr
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 title claims abstract description 51
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 24
- 108091005946 superfolder green fluorescent proteins Proteins 0.000 claims abstract description 22
- 108090000790 Enzymes Proteins 0.000 claims abstract description 12
- 102000004190 Enzymes Human genes 0.000 claims abstract description 12
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 4
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 4
- 239000013612 plasmid Substances 0.000 claims description 18
- 241000588724 Escherichia coli Species 0.000 claims description 14
- 108091006047 fluorescent proteins Proteins 0.000 claims description 13
- 102000034287 fluorescent proteins Human genes 0.000 claims description 13
- 239000002773 nucleotide Substances 0.000 claims description 13
- 125000003729 nucleotide group Chemical group 0.000 claims description 13
- 238000013518 transcription Methods 0.000 claims description 9
- 230000035897 transcription Effects 0.000 claims description 9
- 238000000855 fermentation Methods 0.000 claims description 8
- 230000004151 fermentation Effects 0.000 claims description 8
- 108091023040 Transcription factor Proteins 0.000 claims description 7
- 102000040945 Transcription factor Human genes 0.000 claims description 7
- 230000027455 binding Effects 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 5
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 5
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 5
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 5
- 235000004279 alanine Nutrition 0.000 claims description 5
- 229960001230 asparagine Drugs 0.000 claims description 5
- 235000009582 asparagine Nutrition 0.000 claims description 5
- 235000003704 aspartic acid Nutrition 0.000 claims description 5
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 5
- 229960000310 isoleucine Drugs 0.000 claims description 5
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 5
- 229930182817 methionine Natural products 0.000 claims description 5
- 239000004474 valine Substances 0.000 claims description 5
- 241000186226 Corynebacterium glutamicum Species 0.000 claims description 3
- 108020004414 DNA Proteins 0.000 claims description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 3
- 229940024606 amino acid Drugs 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 235000001014 amino acid Nutrition 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 241001013691 Escherichia coli BW25113 Species 0.000 claims 1
- 108700008625 Reporter Genes Proteins 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 102000004169 proteins and genes Human genes 0.000 abstract description 2
- 102000034356 gene-regulatory proteins Human genes 0.000 description 13
- 108091006104 gene-regulatory proteins Proteins 0.000 description 13
- 238000005457 optimization Methods 0.000 description 7
- 239000012634 fragment Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 5
- 238000003752 polymerase chain reaction Methods 0.000 description 5
- 238000010276 construction Methods 0.000 description 4
- 150000003951 lactams Chemical group 0.000 description 4
- 230000003321 amplification Effects 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 229920001007 Nylon 4 Polymers 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229910052564 epsomite Inorganic materials 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 150000003235 pyrrolidines Chemical class 0.000 description 1
- 108010054624 red fluorescent protein Proteins 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/91194—Transferases (2.) transferring sulfur containing groups (2.8)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开了一种低背景、高信号强度的2‑吡咯烷酮生物传感器及应用，属于基因工程技术领域。本发明提供了一种改进的2‑吡咯烷酮的生物传感器，在原有基础上将报告基因mCherry优化为sfGFP，同时对调控因子chnR进行改造，减少了原信号蛋白的泄露表达，增强了该传感器对不同浓度的2‑吡咯烷酮的信号响应的差异性，可更好用于对2‑吡咯烷酮合成相关酶和菌的定向进化。
Description
技术领域
本发明涉及一种低背景、高信号强度的2-吡咯烷酮生物传感器及应用，属于基因工程技术领域。
背景技术
2-吡咯烷酮(2-Pyrrolidone,2P)，又称2-氧代吡咯烷、γ-丁内酰胺，是一类具有一个五元内酰胺环的吡咯烷类化合物，广泛存在于天然产物和各类人工合成的化合物当中。2-吡咯烷酮是生产聚乙烯吡咯烷酮、锦纶-4和脑复康(酰胺吡咯烷酮)等多种化合物的前体，在医药领域和工业领域具有广泛且重要的用途。
2-吡咯烷酮可由生物法合成。近年来已经有一些国内外的文献报道了关于使用微生物生产2-吡咯烷酮。目前产量最高的是，Tong Un Chae通过对大肠杆菌的改造，产量可达54g/L。Chae T U,Ko Y S,Hwang K S,et al.Metabolic engineering of Escherichiacoli for the production of four-,five-and six-carbon lactams.Metab Eng，2017,41:82-91)β-丙氨酸CoA转移酶(CoAtransferase,Act)催化的ω-氨基酸的活化，然后自发环化合成2-吡咯烷酮，其中Act是生产关键限速酶。Jay D.Keasling等基于调控蛋白开发了内酰胺生物传感器，可特异性、以浓度依赖性检测ε-己内酰胺、δ-戊内酰胺和丁内酰胺，从而筛选定向进化后的菌株或酶。
目前还没有利用生物传感器筛选定向改造关键限速酶高产2-吡咯烷酮菌株的报道，由于现有的生物传感器对2-吡咯烷酮的灵敏性较低，导致在实际应用中荧光弱、可能出现假阳性，难以真正应用。
发明内容
本发明提供一种2-吡咯烷酮的生物传感器，含有启动子Pcon、ChnR编码基因，启动子Pb和荧光蛋白编码基因sfGFP；所述启动子Pb上具有转录因子结合位点，所述启动子Pb调控荧光蛋白编码基因的表达；所述启动子Pcon调控ChnR基因的表达；所述启动子Pcon和启动子Pb的转录方向相反；所述转录因子结合位点的核苷酸序列如SEQ ID NO.5所示。
在一种实施方式中，所述启动子Pcon的核苷酸序列如SEQ ID NO.1所示；所述ChnR编码基因的核苷酸序列如SEQ ID NO.2或SEQ ID NO.6所示；所述启动子Pb的核苷酸序列如SEQ ID NO.3所示；所述荧光蛋白编码基因sfGFP的核苷酸序列如SEQ ID NO.4所示。
在一种实施方式中，所述生物传感器以pBbS5C-RFP为质粒骨架。
本发明还提供了含有所述生物传感器的重组微生物细胞。
在一种实施方式中，所述微生物包括但不限于大肠杆菌或谷氨酸棒杆菌。
在一种实施方式中，所述大肠杆菌为大肠杆菌BW25113。
在一种实施方式中，所述ChnR编码基因是在SEQ ID NO.2所示基因编码的氨基酸的基础上，将第121位缬氨酸突变为丙氨酸，将第230位甲硫氨酸突变为异亮氨酸，并将第236位天冬氨酸突变为天冬酰胺。
本发明还提供了一种提高生物传感器检测灵敏度的方法，所述方法是将所述生物传感器的ChnR基因编码的氨基酸序列的第121位缬氨酸突变为丙氨酸，将第230位甲硫氨酸突变为异亮氨酸，并将第236位天冬氨酸突变为天冬酰胺，获得SEQ ID NO.6所示的序列。
本发明还提供了所述生物传感器在筛选2-吡咯烷酮高产菌株、高活力的2-吡咯烷酮合成关键性酶等方面的应用。
在一种实施方式中，所述筛选2-吡咯烷酮高产菌株是将所述生物传感器转入目的菌株细胞内，将待筛选的菌株在一定条件下培养一段时间，根据菌株发酵液的荧光强度筛选2-吡咯烷酮高产菌株。
有益效果：本发明提供了一种改进的2-吡咯烷酮的生物传感器，在原有基础上将报告基因mCherry优化为sfGFP，同时对调控因子chnR进行改造，减少了原信号蛋白的泄漏表达，增强了该传感器对不同浓度的2-吡咯烷酮的信号响应的差异性，可更好用于对2-吡咯烷酮合成相关酶和菌的定向进化。
附图说明
图1为报告基因优化前后的荧光响应对比。
图2为2-吡咯烷酮生物传感器调控蛋白ChnR位点优化。
图3为调控蛋白ChnR优化前后的荧光响应对比。
具体实施方式
培养基：
M9培养基：葡萄糖4.0g/L，Na2HPO4 6.78g/L，KH2PO4 3.0g/L，NaCl 0.5g/L，NH4Cl1.0g/L，MgSO4·7H2O 0.493g/L，CaCl2 11mg/L。
实施例1生物传感器的荧光蛋白的优化
生物传感器的构建：生物传感器以pBbS5C-RFP质粒(公开于论文《Development ofa Transcription Factor-Based Lactam Biosensor》)为骨架，含有启动子Pcon、调控蛋白的编码基因ChnR，启动子Pb和荧光蛋白编码基因sfGFP；所述启动子Pcon、调控蛋白的编码基因ChnR和启动子Pb以及报告基因sfGFP位于同一载体或基因组上；所述启动子Pb上具有转录因子结合位点(SEQ ID NO.5所示)，所述启动子Pb调控荧光蛋白编码基因sfGFP的表达；所述启动子Pcon调控ChnR基因的表达；所述启动子Pcon和启动子Pb的转录方向相反。所述启动子Pcon的核苷酸序列如SEQ ID NO.1所示；所述ChnR编码基因的核苷酸序列如SEQ ID NO.2所示；所述启动子Pb的核苷酸序列如SEQ ID NO.3所示；所述荧光蛋白编码基因sfGFP的核苷酸序列如SEQ ID NO.4所示。。
本发明构建的生物传感器的工作原理为：在环境中含有2-吡咯烷酮的情况下，受Pcon启动子调控表达的转录因子ChnR结合环境中的2-吡咯烷酮诱发DNA结合域的构象变化，并结合在位于启动子Pb上的转录因子结合位点ttgtttggatc(SEQ ID NO.5所示)，激活转录，从而调控启动子Pb表达荧光蛋白。2-吡咯烷酮浓度越高，Pb调控转录的强度越强，从而荧光信号越强。
以pBbSLactamC-mCherry为质粒模板，将基因mCherry替换成sfGFP，构建质粒pBb-ChnR-sfGFP。具体操作如下：
以pBbSLactamC-mCherry(pBb-mCherry)质粒(公开于论文《Development of aTranscription Factor-Based Lactam Biosensor》)为模板，使用引物扩增质粒主片段，并以合成sfGFP基因为模板扩增sfGFP基因：
pBbBBF：ggtaccctccattacgacatg；
pBbBBR：aggatccaaactcgagtaagg；
sfGFPpBbF：ccttactcgagtttggatcctcatttgtacagttcatccatac；
sfGFPpBbR：catgtcgtaatggagggtaccatgcgtaaaggcgaagagc；
sfGFPCF:cacccgaaggtgagccagtgtgactc；
sfGFPCR：catccaagccttgtgattgcattcctgcg；
分别克隆质粒载体和sfGFP片段，37℃下使用DPN1酶消化2小时消除模板质粒，经DNA纯化试剂盒纯化后，通过Gibson方法将载体片段相连接，使用引物将sfGFPCF与sfGFPCR通过PCR验证并测序比对，确定pBb-ChnR-sfGFP质粒构建成功。
实施例2含生物传感器的大肠杆菌工程菌株的构建
将实施例1构建的重组质粒pBb-ChnR-sfGFP转化至大肠杆菌BW25113中，得到的菌株命名为pBb-sfGFP。并将质粒pBbSLactamC-mCherry转化至大肠杆菌DW25113中，得到的菌株命名为pBb-mCherry，作为对照。将pBb-sfGFP和pBb-mCherry在LB培养基中用试管于37℃培养12小时，获得种子液；将50mL M9培养基加到500mL摇瓶中，在加入0、0.3、0.6、0.9、1.2、1.5mM终浓度2-吡咯烷酮情况下，按10％的接种量接种，使接种后的初始OD为0.5，发酵温度为37℃，摇床转速200rpm，发酵24小时。用酶标仪(TECON INFINITE E PLEX)以激发波长488nm，发射波长507nm检测确定sfGFP荧光强度；以激发波长575nm，发射波长620nm检测确定发酵液中的mCherry荧光强度。
图1显示了摇瓶发酵过程随着加入底物2-吡咯烷酮产量的变化两种荧光蛋白的变化。随着产生的2-吡咯烷酮增加，sfGFP和mCherry荧光蛋白产生的荧光强度增加，并呈现浓度相关性。sfGFP荧光泄漏低、对不同浓度的2-吡咯烷酮的荧光信号的差异性大，说明sfGFP较mCherry作为报告基因更优。
实施例3 2-吡咯烷酮的大肠杆菌工程菌株关键酶进化生物传感器的调控蛋白优化
图2为生物传感器调控蛋白ChnR基因优化回路构建示意图，以实施例1构建的pBb-sfGFP为质粒模板，将调控蛋白ChnR第121位缬氨酸突变为丙氨酸，并将第230位甲硫氨酸突变为异亮氨酸，并将第236位天冬氨酸突变为天冬酰胺。
具体操作如下：
以实施例1构建的pBb-sfGFP为模板设计扩增引物实行点突变：
ChnR121F：ctccatcacctcaatggcgaataagGCTtttgattatgatatcgcttcgatccgaatc；
ChnR236R：gcagcaggggaattaccaaaATTgactttaaattttctGATtaaatgaggcacgctcatcttgac；
ChnR121BBF：gtcaagatgagcgtgcctcatttaATCagaaaatttaaagtcAATtttggtaattcccctgctgc；
ChnR121BBR：gattcggatcgaagcgatatcataatcaaaAGCcttattcgccattgaggtgatggag；
ChnRCF：gcgatgcctcttgggatacccaagtg；
ChnRCR：ctcgggtcatatggctctgatcgc；
以质粒pBb-sfGFP作为调控蛋白ChnR扩增模板，使用三位点点突变引物ChnR121F与ChnR236R通过PCR扩增得到第121位缬氨酸突变为丙氨酸、第230位甲硫氨酸突变为异亮氨酸、第236位天冬氨酸突变为天冬酰胺的目的片段。37℃下使用DPN1酶消化2小时消除模板质粒，经DNA纯化试剂盒纯化后，通过Gibson将PCR扩增的目的片段与质粒pBb-sfGFP的主干片段相连，使用引物ChnRCF与ChnRCR PCR验证并测序比对，确定质粒pBb-ChnR-M1-sfGFP构建成功。将重组质粒转化至大肠杆菌DW25113中，得到的菌株命名为pBb-ChnR。
实施例4利用调控蛋白ChnR优化系统在大肠杆菌中监测2-吡咯烷酮的浓度变化
将实施例2中构建的调控蛋白优化菌株pBb-ChnR和实施例1中构建的菌株pBb-sfGFP分别在加入不同浓度2-吡咯烷酮情况下，对比两株菌的sfGFP产生的荧光。将菌株pBb-ChnR和pBb-sfGFP分别在LB培养基中，用试管于37℃培养12小时，获得种子液；将50mLM9培养基加到500mL摇瓶中，在加入0、0.3、0.6、0.9、1.2、1.5mM终浓度2-吡咯烷酮情况下，按10％的接种率接种，发酵温度为37℃，摇床转速200rpm，发酵24小时。2-吡咯烷酮会与调控蛋白ChnR结合，形成的结合物能够与Pb位点结合，使启动子起始转录，激活报告基因sfGFP荧光蛋白的表达，当菌株的生长环境中加入2-吡咯烷酮时Pb启动子就会开始转录，进而生成绿色荧光蛋白。该生物传感器能够响应不同浓度的2-吡咯烷酮，进而调控不同强度的绿色荧光蛋白表达。酶标仪(TECON INFINITE E PLEX)以激发波长488nm，发射波长507nm检测荧光强度。
图3显示了摇瓶发酵过程随着加入底物2-吡咯烷酮产量的变化荧光蛋白的变化。随着2-吡咯烷酮浓度增加，sfGFP荧光蛋白产生的荧光强度增加，并呈现浓度依赖性。对比未优化调控蛋白菌株，ChnR优化后的生物传感器对不同浓度的2-吡咯烷酮的信号响应的差异性进一步增大，可以更好地区分开合成不同浓度的2-吡咯烷酮菌株。
虽然本发明已以较佳实施例公开如上，但其并非用以限定本发明，任何熟悉此技术的人，在不脱离本发明的精神和范围内，都可做各种的改动与修饰，因此本发明的保护范围应该以权利要求书所界定的为准。
Claims (6)
1.一种2-吡咯烷酮的生物传感器，其特征在于，以pBbS5C-RFP为质粒骨架，含有启动子Pcon、ChnR编码基因，启动子Pb和荧光蛋白编码基因sfGFP；所述启动子Pb上具有转录因子结合位点，所述启动子Pb调控荧光蛋白编码基因的表达；所述启动子Pcon调控ChnR基因的表达；所述启动子Pcon和启动子Pb的转录方向相反；所述转录因子结合位点的核苷酸序列如SEQ ID NO.5所示；
所述ChnR编码基因是在SEQ ID NO.2所示基因编码的氨基酸的基础上，将第121位缬氨酸突变为丙氨酸，将第230位甲硫氨酸突变为异亮氨酸，并将第236位天冬氨酸突变为天冬酰胺，获得SEQ ID NO.6所示的基因；所述启动子Pcon的核苷酸序列如SEQ ID NO.1所示；所述启动子Pb的核苷酸序列如SEQ ID NO.3所示；所述荧光蛋白编码基因sfGFP的核苷酸序列如SEQ ID NO.4所示。
2.根据权利要求1所述的生物传感器，其特征在于，所述启动子Pcon、ChnR编码基因，启动子Pb和荧光蛋白编码基因sfGFP位于同一质粒或基因组DNA上。
3.含有权利要求1或2所述生物传感器的重组微生物细胞，其特征在于，所述微生物为大肠杆菌或谷氨酸棒杆菌。
4.根据权利要求3所述的重组微生物细胞，其特征在于，所述大肠杆菌为大肠杆菌BW25113。
5.权利要求1或2所述的生物传感器在筛选2-吡咯烷酮高产菌株、高活力的2-吡咯烷酮合成关键性酶中的应用，其特征在于，所述菌株为大肠杆菌或谷氨酸棒杆菌。
6.根据权利要求5所述的应用，其特征在于，所述筛选2-吡咯烷酮高产菌株是将所述生物传感器转入目的菌株细胞内，将待筛选的菌株在一定条件下培养一段时间，根据菌株发酵液的荧光强度筛选2-吡咯烷酮高产菌株。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310068615.7A CN116790647B (zh) | 2023-02-06 | 2023-02-06 | 一种低背景、高信号强度的2-吡咯烷酮生物传感器及应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310068615.7A CN116790647B (zh) | 2023-02-06 | 2023-02-06 | 一种低背景、高信号强度的2-吡咯烷酮生物传感器及应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116790647A CN116790647A (zh) | 2023-09-22 |
| CN116790647B true CN116790647B (zh) | 2024-04-16 |
Family
ID=88042686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310068615.7A Active CN116790647B (zh) | 2023-02-06 | 2023-02-06 | 一种低背景、高信号强度的2-吡咯烷酮生物传感器及应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116790647B (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102216464A (zh) * | 2008-08-29 | 2011-10-12 | 纳幕尔杜邦公司 | 操纵snf1蛋白激酶活性用于改变含油生物中的油含量 |
| CN110684792A (zh) * | 2019-10-14 | 2020-01-14 | 江南大学 | 一种可反复消除的乙醇酸传感器及其构建方法 |
| CN110724702A (zh) * | 2019-11-15 | 2020-01-24 | 中国科学院天津工业生物技术研究所 | 一种丙酮酸(pyr)的特异性生物传感器及其应用 |
| CN112481278A (zh) * | 2020-12-09 | 2021-03-12 | 江南大学 | 一种基于aip诱导的生物传感器及其应用 |
| CN114752589A (zh) * | 2022-06-16 | 2022-07-15 | 森瑞斯生物科技(深圳)有限公司 | 谷氨酸脱羧酶突变体及在生产γ-氨基丁酸中的应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112243442A (zh) * | 2018-04-10 | 2021-01-19 | 桑昆血液供给基金会 | 嵌合Notch受体 |
-
2023
- 2023-02-06 CN CN202310068615.7A patent/CN116790647B/zh active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102216464A (zh) * | 2008-08-29 | 2011-10-12 | 纳幕尔杜邦公司 | 操纵snf1蛋白激酶活性用于改变含油生物中的油含量 |
| CN110684792A (zh) * | 2019-10-14 | 2020-01-14 | 江南大学 | 一种可反复消除的乙醇酸传感器及其构建方法 |
| CN110724702A (zh) * | 2019-11-15 | 2020-01-24 | 中国科学院天津工业生物技术研究所 | 一种丙酮酸(pyr)的特异性生物传感器及其应用 |
| CN112481278A (zh) * | 2020-12-09 | 2021-03-12 | 江南大学 | 一种基于aip诱导的生物传感器及其应用 |
| CN114752589A (zh) * | 2022-06-16 | 2022-07-15 | 森瑞斯生物科技(深圳)有限公司 | 谷氨酸脱羧酶突变体及在生产γ-氨基丁酸中的应用 |
Non-Patent Citations (2)
| Title |
|---|
| Development of a Transcription Factor-Based Lactam Biosensor;Jingwei Zhang等;《ACS Synth Biol.》;第6卷(第3期);摘要，第 441 页左栏第 1 段、右栏第 1-2 段，第 443 页右栏第5段，第441页左栏第1段，图 2 * |
| Engineering and characterization of a superfolder green fluorescent protein;Jean-Denis Pédelacq等;《Nat Biotechnol.》;第24卷(第1期);第79页左栏最后1段，第82页左栏第1段，第85页左栏第3段 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116790647A (zh) | 2023-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230193215A1 (en) | Mutant glucose oxidase (god) having improved thermal stability and gene and application thereof | |
| US10865404B1 (en) | Aspartase mutant, recombinant expression vector and recombinant bacterium containing aspartase mutant, and use thereof | |
| JPH04507346A (ja) | アルカリ性タンパク質分解酵素およびその製造方法 | |
| CN107794273B (zh) | 一种合成dl-丙氨酸的三基因共表达载体及应用 | |
| CN113151198B (zh) | 一种γ-谷酰胺甲胺合成酶的突变体，其编码基因、氨基酸序列及其应用 | |
| EP0035831B1 (en) | Method for making genetically modified microorganisms | |
| CN112251428B (zh) | 一种谷氨酸脱羧酶突变体及其在生产γ-氨基丁酸中的应用 | |
| CN116790647B (zh) | 一种低背景、高信号强度的2-吡咯烷酮生物传感器及应用 | |
| CN113005071A (zh) | 一种SsgA编码基因SMDS_1018的用途、重组菌株及其构建方法 | |
| CN110592109B (zh) | 一种spoT基因改造的重组菌株及其构建方法与应用 | |
| CN107541482A (zh) | 一种构建大肠杆菌高效分泌表达转肽酶Sortase A的方法 | |
| CN109943542A (zh) | 一种用于阿扎那韦中间体生产的醇脱氢酶 | |
| CN110564742B (zh) | 一种yebN基因改造的重组菌株及其构建方法与应用 | |
| CN111500614A (zh) | 高效催化l-苏氨酸合成2,5-dmp的质粒及其构建与应用 | |
| CN101978055B (zh) | 新型过氧化氢生成型nadh氧化酶及编码其的dna | |
| CN115894639B (zh) | 一种辅助侵染蛋白残基突变体蛋白、其重组体及在外泌酶固定化工艺中的应用 | |
| CN116240187B (zh) | 脯氨酰羟化酶α1亚基突变体、编码基因及其在催化脯氨酸羟基化中的应用 | |
| CN115838712B (zh) | 具有肌肽水解酶功能的蛋白酶及其在l-肌肽合成中的应用 | |
| CN113699174B (zh) | 一种自诱导表达系统及其在促进基因表达中的应用 | |
| CN114686389B (zh) | 一种增强vgbS基因转录水平的谷氨酰胺转氨酶高产菌株及其制备与发酵方法 | |
| CN114540397B (zh) | 增强调控蛋白表达以提高谷氨酰胺转氨酶发酵水平的方法 | |
| CN116121285B (zh) | 一种2-吡咯烷酮生物传感器的构建及应用 | |
| RU2813283C2 (ru) | Рекомбинантный штамм на основе escherichia coli, способ его конструирования и его применение | |
| CN113817761B (zh) | 一种无三羧酸循环的大肠杆菌底盘菌及其构建方法与应用 | |
| RU2731289C2 (ru) | Способ конструирования на основе бактерий рода Rhodococcus штамма-биокатализатора, обладающего нитрилазной активностью и повышенной операционной стабильностью, рекомбинантный штамм бактерий Rhodococcus rhodochrous, полученный таким способом, способ синтеза акриловой кислоты с использованием этого штамма в качестве биокатализатора |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20230918 Address after: 518067 b402, blocks a and B, Nanshan medical device Industrial Park, No. 1019, Nanhai Avenue, Yanshan community, merchants street, Nanshan District, Shenzhen City, Guangdong Province Applicant after: Senris Biotechnology (Shenzhen) Co.,Ltd. Address before: 261000 Binhai (Xiaying) Economic Development Zone, Changyi City, Weifang City, Shandong Province, south of Xinqu 1st Road and east of Xinqu Dongsi Road Applicant before: Weifang Yasen Biotechnology Co.,Ltd. |
|
| TA01 | Transfer of patent application right | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |